Jeffrey Hager serves as Executive at IDEAYA Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Hager has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 26, 2019 involved exercising options for 5,197 shares valued at $22.4K.
Jeffrey Hager currently holds 127,853 shares of IDEAYA Biosciences, Inc. (IDYA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Hager has been a net neutral trader of IDYA stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey Hager's most recent insider trade was on Jul 26, 2019, when they sold 5,197 shares at $4.31 per share.
Get notified when new Form 4 filings are submitted
| 7,145 |
| $4.31 |
| Discretionary |
| Jun 19, 2019 | IDYA | $37.2K | Option Exercise | 8,628 | $4.31 | Discretionary |